Cargando…

Reply: Vitamin C as a Possible Therapy for COVID-19

Detalles Bibliográficos
Autores principales:	Kim, Sun Bean, Yeom, Joon Sup
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335644/ https://www.ncbi.nlm.nih.gov/pubmed/32468742 http://dx.doi.org/10.3947/ic.2020.52.2.224

Ejemplares similares

Vitamin C as a Possible Therapy for COVID-19
por: Hemilä, Harri, et al.
Publicado: (2020)

Reply to: Vitamin C as a promoter of γδ T cells
por: Kouakanou, Léonce, et al.
Publicado: (2021)

Reply to Vitamin D deficiency in COVID-19: mixing up cause and consequence
por: Chakhtoura, M., et al.
Publicado: (2021)

Early triple antiviral therapy for COVID-19 – Authors' reply
por: Hung, Ivan Fan-Ngai, et al.
Publicado: (2020)

Reply to: COVID-19 and Coagulopathy
por: Rodríguez, Cristina, et al.
Publicado: (2021)

Tocilizumab in COVID-19 therapy: who benefits, and how? – Authors' reply
por: Horby, Peter, et al.
Publicado: (2021)

Reply to Braillon: Vitamin C to Pregnant Smokers and Infant Airway Function: Missing the Forest for the Trees?
por: McEvoy, Cindy T., et al.
Publicado: (2019)

Cancer and COVID-19 – Authors' reply
por: Kuderer, Nicole M, et al.
Publicado: (2020)

Remdesivir and COVID-19 – Authors' reply
por: Wang, Yeming, et al.
Publicado: (2020)

Reply to: Hypertension and severe COVID-19
por: Shibata, Shigeru, et al.
Publicado: (2023)

Reply: COVID-19, A and Hypersensitivity Pneumonitis
por: Shin, Hyoung-Shik
Publicado: (2020)

COVID-19 Vasculopathy and Post–COVID-19 Phenomenon: Reply
por: Akgul, Ahmet
Publicado: (2021)

In Reply to ‘Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations’
por: Fernandes, Guillaume, et al.
Publicado: (2022)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Reply to Epelbaum: Standards and Stereotypes in COVID-19
por: Ziehr, David R., et al.
Publicado: (2020)

In Reply to ‘COVID-19–Associated Kidney Injury’
por: Patel, Niralee, et al.
Publicado: (2020)

COVID-19 in patients with HIV – Authors' reply
por: Miró, José M, et al.
Publicado: (2020)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

Vitamin C therapy in septic shock
por: Muzaffar, Syed Nabeel, et al.
Publicado: (2022)

On Ventricular Aneurysms, Thrombi, and COVID-19: Reply
por: Hui, Dawn S., et al.
Publicado: (2021)

Surgical Training in the Era of COVID-19: Reply
por: Fuller, Stephanie
Publicado: (2021)

COVID-19 and preterm birth – Authors' reply
por: Choudhary, Rahul, et al.
Publicado: (2021)

Neuropsychiatric disorders and COVID-19 – Authors' reply
por: Taquet, Maxime, et al.
Publicado: (2021)

COVID-19 and myocardial infarction – Authors' reply
por: Katsoularis, Ioannis, et al.
Publicado: (2021)

Fluvoxamine for the treatment of COVID-19 – Author's reply
por: Reis, Gilmar, et al.
Publicado: (2022)

COVID-19 research in LMICs – Authors' reply
por: Torres, Irene, et al.
Publicado: (2021)

Prone Positioning in COVID-19 ARDS: Reply
por: Zarantonello, Francesco, et al.
Publicado: (2023)

Early Detection and Therapy Is the Key for the Management of Type A Aortic Dissection With COVID-19: Reply
por: Fukuhara, Shinichi
Publicado: (2021)

Reply to Noel-Savina and collaborators: D(M) and V(C) impairment after COVID-19
por: Gille, Thomas, et al.
Publicado: (2023)

Reply to Olschewski et al.: TMEM16A Potentiation: Possible Drawbacks
por: Danahay, Henry L., et al.
Publicado: (2020)

Authors’ Reply to Critical Comment on “Vitamin D Level in Alopecia Areata”
por: Bhat, Yasmeen Jabeen, et al.
Publicado: (2018)

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Author's reply
por: Meduri, G. Umberto, et al.
Publicado: (2021)

Frailty and mortality in patients with COVID-19 – Authors' reply
por: McCarthy, Kathryn, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?()
por: López Reboiro, M.L., et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19 – Authors' reply
por: Hayem, Gilles, et al.
Publicado: (2020)

Psychiatric and neuropsychiatric syndromes and COVID-19 – Authors' reply
por: Rogers, Jonathan P, et al.
Publicado: (2020)

Management of diabetes in patients with COVID-19 – Authors' reply
por: Bornstein, Stefan R, et al.
Publicado: (2020)

Surgery during the COVID-19 pandemic – Authors' reply
por: COVIDSurg Collaborative
Publicado: (2020)

Reply to: “Liver fibrosis and adverse outcomes in COVID-19”
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2bak8oi9mseh3nep516fsht8n7